Genetic insights into Tietz albinism‐deafness syndrome: A new dominant‐negative mutation in MITF

Kohei Yamamoto,Ken Okamura,Kazumasa Wakamatsu,Shosuke Ito,Kozue Akabane,Yosuke Arai,Junnosuke Kawaguchi,Yutaka Hozumi,Tamio Suzuki
DOI: https://doi.org/10.1111/pcmr.13166
2024-03-06
Pigment Cell & Melanoma Research
Abstract:We uncovered a previously unreported c.637G>C (p.Glu213Gln) mutation in the MITF in a patient with Tietz albinism‐deafness syndrome (TADS), elucidating its genetic and clinical significance. The combined results from histopathological examination, transmission electron microscopy analysis, and melanin quantification underscored the substantial impairment caused by the p.Glu213Gln variant on melanosome maturation and melanin synthesis. Functional analysis demonstrated the dominant‐negative effect of p.Glu213Gln along with other known mutations (p.Glu213Asp and p.Arg217del) within the basic domain of MITF, highlighting their collective impairment of DNA‐binding ability. These findings significantly contribute to our comprehension of the fundamental pathogenic mechanisms involved in TADS. Tietz albinism‐deafness syndrome (TADS) is a rare and severe manifestation of Waardenburg syndrome that is primarily linked to mutations in MITF. In this report, we present a case of TADS resulting from a novel c.637G>C mutation in MITF (p.Glu213Gln; GenBank Accession number: NM_000248). A 3‐year‐old girl presented with congenital generalized hypopigmentation of the hair, skin, and irides along with complete sensorineural hearing loss. Histopathological and electron microscopy investigations indicated that this variant did not alter the number of melanocytes in the skin but significantly impaired melanosome maturation within melanocytes. Comprehensive melanin analysis revealed marked reductions in both eumelanin (EM) and pheomelanin (PM) rather than changes in the EM‐to‐PM ratio observed in oculocutaneous albinism. We conducted an electrophoretic mobility shift assay to investigate the binding capability of the identified variant to DNA sequences containing the E‐box motif along with other known variants (p.Arg217del and p.Glu213Asp). Remarkably, all three variants exhibited dominant‐negative effects, thus providing novel insights into the pathogenesis of TADS. This study sheds light on the genetic mechanisms underlying TADS and offers a deeper understanding of this rare condition and its associated mutations in MITF.
dermatology,oncology,cell biology
What problem does this paper attempt to address?